{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:12:29Z","timestamp":1790100749948,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ajpc.2026.101719","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:53:17Z","timestamp":1782492797000},"page":"101719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Changes in statin therapy eligibility under the 2026 versus 2018 dyslipidemia guidelines"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3233-7833","authenticated-orcid":false,"given":"Jared A.","family":"Spitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith E.","family":"Metlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bede","family":"Nriagu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Ade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britton","family":"Scheuermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Dastmalchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpc.2026.101719_bib0001","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1161\/CIR.0000000000001256","article-title":"Forecasting the burden of cardiovascular disease and stroke in the United States through 2050-prevalence of risk factors and disease: a presidential advisory from the American Heart Association","volume":"150","author":"Joynt Maddox","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2026.101719_bib0002","first-page":"e41","article-title":"2025 Heart Disease and Stroke statistics: a report of US and global data from the American Heart Association","volume":"151","author":"Martin","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2026.101719_bib0003","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ajpc.2026.101719_bib0004","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2026.101719_bib0005","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of blood Cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2026.101719_bib0006","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/jama.2024.12537","article-title":"Projected changes in statin and antihypertensive therapy eligibility with the AHA PREVENT cardiovascular risk equations","volume":"332","author":"Diao","year":"2024","journal-title":"Jama"},{"key":"10.1016\/j.ajpc.2026.101719_bib0007","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7326\/M17-3011","article-title":"Clinical implications of revised pooled cohort equations for estimating atherosclerotic cardiovascular disease risk","volume":"169","author":"Yadlowsky","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajpc.2026.101719_bib0008","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the american heart association's prevent equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2026.101719_bib0009","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/CIRCULATIONAHA.124.071233","article-title":"The role of race in cardiovascular disease risk prediction","volume":"151","author":"Ndumele","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2026.101719_bib0010","first-page":"e1154","article-title":"2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of dyslipidemia: a report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"153","author":"Members","year":"2026","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2026.101719_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.102546","article-title":"Shifting thresholds: changes in antihypertensive eligibility under the 2025 versus 2017 hypertension guidelines","volume":"5","author":"Metlock","year":"2026","journal-title":"JACC Adv"},{"key":"10.1016\/j.ajpc.2026.101719_bib0012","first-page":"1","article-title":"National Health and Nutrition Examination Survey: estimation procedures, 2007-2010","volume":"2","author":"Mirel","year":"2013","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.ajpc.2026.101719_bib0013","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1001\/jama.2013.280532","article-title":"Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile","volume":"310","author":"Martin","year":"2013","journal-title":"Jama"},{"key":"10.1016\/j.ajpc.2026.101719_bib0014","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2026.101719_bib0015","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Goff","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajpc.2026.101719_bib0016","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American Heart Association\u2019s PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2026.101719_bib0017","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1161\/01.ATV.13.1.90","article-title":"Arterial alterations with aging and high blood pressure. A noninvasive study of carotid and femoral arteries","volume":"13","author":"Benetos","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.ajpc.2026.101719_bib0018","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1373\/clinchem.2006.077180","article-title":"Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values","volume":"53","author":"Levey","year":"2007","journal-title":"Clin Chem"},{"issue":"Suppl 1","key":"10.1016\/j.ajpc.2026.101719_bib0019","first-page":"S62","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajpc.2026.101719_bib0020","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajpc.2026.101719_bib0021","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jacc.2025.08.001","article-title":"Use of risk assessment to guide decision-making for blood pressure management in the primary prevention of cardiovascular disease: a scientific statement from the American Heart Association and American College of Cardiology","volume":"86","author":"Khan","year":"2025","journal-title":"JACC"},{"key":"10.1016\/j.ajpc.2026.101719_bib0022","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2026.101719_bib0023","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101719_bib0024","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa2405182","article-title":"Inflammation, cholesterol, lipoprotein(a), and 30-year cardiovascular outcomes in women","volume":"391","author":"Ridker","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpc.2026.101719_bib0025","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jacl.2026.02.006","article-title":"Low-density lipoprotein cholesterol lowering and risk of major adverse cardiovascular events in primary prevention trials: a meta-analysis","volume":"20","author":"Kalra","year":"2026","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.ajpc.2026.101719_bib0026","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1001\/jamacardio.2020.1731","article-title":"Association of normal systolic blood pressure level with cardiovascular disease in the absence of risk factors","volume":"5","author":"Whelton","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ajpc.2026.101719_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109980","article-title":"Management of dyslipidemia and atherosclerotic cardiovascular risk in prediabetes","volume":"190","author":"Neves","year":"2022","journal-title":"Diabet Res Clin Pract"},{"key":"10.1016\/j.ajpc.2026.101719_bib0028","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/CIRCRESAHA.121.319811","article-title":"Social determinants of cardiovascular disease","volume":"130","author":"Powell-Wiley","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpc.2026.101719_bib0029","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.123.010763","article-title":"PREVENT equations: a new era in cardiovascular disease risk assessment","volume":"17","author":"Razavi","year":"2024","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ajpc.2026.101719_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2026.101566","article-title":"Sex differences in the association between cumulative social risk and life\u2019s essential 8 cardiovascular health scores in U.S. adults","author":"Metlock","year":"2026","journal-title":"Am J Preven Cardiol"},{"key":"10.1016\/j.ajpc.2026.101719_bib0031","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.7326\/M23-0720","article-title":"Disparities in guideline-recommended statin use for prevention of atherosclerotic cardiovascular disease by race, ethnicity, and gender: a nationally representative cross-sectional analysis of adults in the United States","volume":"176","author":"Frank","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajpc.2026.101719_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0311724","article-title":"Financial resources, access to care, and quality of care mediate racial disparities in statin usage for secondary prevention","volume":"19","author":"Wong","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpc.2026.101719_bib0033","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jamacardio.2016.4700","article-title":"National trends in statin use and expenditures in the US adult population from 2002 to 2013: insights from the medical expenditure Panel Survey","volume":"2","author":"Salami","year":"2017","journal-title":"JAMA Cardiol"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726002941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726002941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:58:30Z","timestamp":1790099910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667726002941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":33,"alternative-id":["S2666667726002941"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101719","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in statin therapy eligibility under the 2026 versus 2018 dyslipidemia guidelines","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101719"}}